These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1644895)

  • 21. Ocular molecules and cells that regulate immune responses in situ.
    Streilein JW; Cousins S; Williamson JS
    Int Ophthalmol; 1990 Oct; 14(5-6):317-25. PubMed ID: 2249909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations.
    Wilbanks GA; Streilein JW
    Immunology; 1990 Nov; 71(3):383-9. PubMed ID: 1702748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The wavelength of light governing intraocular immune reactions.
    Ferguson TA; Mahendra SL; Hooper P; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1788-95. PubMed ID: 1559779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anterior chamber-associated immune deviation.
    Biros D
    Vet Clin North Am Small Anim Pract; 2008 Mar; 38(2):309-21, vi-vii. PubMed ID: 18299009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of inflammation on ocular immune privilege.
    Mo JS; Wang W; Kaplan HJ
    Chem Immunol Allergy; 2007; 92():155-165. PubMed ID: 17264491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis.
    Ohta K; Yamagami S; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2591-9. PubMed ID: 10937571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products.
    Streilein JW; Bradley D
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2700-10. PubMed ID: 1894470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic restrictions and cellular interactions in the induction of anterior chamber associated immune deviation (ACAID).
    Ferguson TA; Kaplan HJ
    Reg Immunol; 1988; 1(1):62-8. PubMed ID: 2978943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of ocular immune responses.
    Streilein JW
    Eye (Lond); 1997; 11 ( Pt 2)():171-5. PubMed ID: 9349408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies.
    Li X; Wang Y; Urso D; O'Rourke J; Cone RE
    Immunology; 2004 Sep; 113(1):44-56. PubMed ID: 15312135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intraocular gamma-interferon on immunoregulatory properties of iris and ciliary body cells.
    Streilein JW; Cousins S; Bradley D
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2304-15. PubMed ID: 1607242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue barriers, immunosuppressive microenvironments, and privileged sites: the eye's point of view.
    Streilein JW
    Reg Immunol; 1993; 5(5):253-68. PubMed ID: 8148235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune privilege: keeping an eye on natural killer T cells.
    Hong S; Van Kaer L
    J Exp Med; 1999 Nov; 190(9):1197-200. PubMed ID: 10544192
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful immunotherapy of an intraocular tumor in mice.
    Schurmans LR; den Boer AT; Diehl L; van der Voort EI; Kast WM; Melief CJ; Toes RE; Jager MJ
    Cancer Res; 1999 Oct; 59(20):5250-4. PubMed ID: 10537305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of immune privilege in the eye and hair follicle.
    Niederkorn JY
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):168-72. PubMed ID: 14582667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological privilege in the eye: a review.
    Tompsett E; Abi-Hanna D; Wakefield D
    Curr Eye Res; 1990 Dec; 9(12):1141-5. PubMed ID: 2091893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular immune responses. I. Priming of A/J mice in the anterior chamber with azobenzenearsonate-derivatized cells induces second-order-like suppressor T cells.
    Wetzig RP; Foster CS; Greene MI
    J Immunol; 1982 Apr; 128(4):1753-7. PubMed ID: 6460810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.